PITTSBURGH, Feb. 9 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced that its Greensboro, N.C., distribution facility has received Verified-Accredited Wholesale Distributors® (VAWD) accreditation from the National Association of Boards of Pharmacy® (NABP). The NABP established the VAWD program in 2004 to help protect the public from the threat of counterfeit drugs affecting the U.S. drug supply.
Mylan North America President Hal Korman stated: "This accreditation provides further reassurance to our valued customers that Mylan's products are of the highest quality and are safeguarded against counterfeit and fraud."
According to IMS Health data, one out of every 12 prescriptions dispensed in the U.S. – branded or generic – is a Mylan product, and most of these are distributed by the company's Greensboro facility.
The VAWD program aims to provide assurance that wholesale distribution facilities operate legitimately, are validly licensed in good standing, and are employing security and best practices for safely distributing prescription drugs from manufacturers to pharmacies and other institutions. Applicants for accreditation undergo an exhaustive criteria compliance review, licensure verification, a survey, background checks and screening through the NABP Clearinghouse.
Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 140 countries and territories. The company maintains one of the industry's broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world's largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies. For more information, please visit www.mylan.com.
The National Association of Boards of Pharmacy is an independent, international and impartial association that assists its member boards and jurisdictions in developing, implementing and enforcing uniform standards for the purpose of protecting the public health.
SOURCE Mylan Inc.
|SOURCE Mylan Inc.|
Copyright©2010 PR Newswire.
All rights reserved